Ads
related to: rgnx
Search results
REGENXBIO Sees Positive Results For Macular Degeneration Therapy
Exec Edge via Yahoo Finance· 8 hours agoBy Karen Roman REGENXBIO Inc. (Nasdaq: RGNX), a clinical-stage biotechnology company, said its...
Down -25.53% in 4 Weeks, Here's Why You Should You Buy the Dip in Regenxbio (RGNX)
Zacks via Yahoo Finance· 3 months agoRegenxbio (RGNX) is technically in oversold territory now, so the heavy selling pressure might have...
Wall Street Analysts Believe Regenxbio (RGNX) Could Rally 102%: Here's is How to Trade
Zacks via Yahoo Finance· 2 years agoThe consensus price target hints at a 101.7% upside potential for Regenxbio (RGNX). While empirical...
REGENXBIO's (RGNX) Hunter Syndrome Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 2 months agoREGENXBIO (RGNX) gains 12% on positive top-line results from the phase I/II/III study of its...
Regenxbio (RGNX) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 year agoRegenxbio (RGNX) delivered earnings and revenue surprises of -12.90% and 10.95%, respectively, for...
Regenxbio Inc (RGNX) President and CEO Kenneth Mills Sells 15,000 Shares
GuruFocus.com via Yahoo Finance· 1 week agoRegenxbio Inc (NASDAQ:RGNX), a biotechnology company focused on the development, commercialization,...
Regenxbio (RGNX) Moves to Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance· 2 years agoRegenxbio (RGNX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the...
Earnings Preview: Regenxbio (RGNX) Q2 Earnings Expected to Decline
Zacks via Yahoo Finance· 2 years agoRegenxbio (RGNX) doesn't possess the right combination of the two key ingredients for a likely...
REGENXBIO (NASDAQ:RGNX) adds US$111m to market cap in the past 7 days, though investors from five...
Simply Wall St. via Yahoo Finance· 5 months agoREGENXBIO Inc. (NASDAQ:RGNX) shareholders should be happy to see the share price up 16% in the last...
REGENXBIO Inc.'s (NASDAQ:RGNX) Stock Has Shown Weakness Lately But Financial Prospects Look Decent:...
Simply Wall St. via Yahoo Finance· 2 years agoREGENXBIO (NASDAQ:RGNX) has had a rough month with its share price down 19%. However, the company's...